OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer
Yinjie Su, Bo Wang, Jian Huang, et al.
Cell Proliferation (2023) Vol. 56, Iss. 7
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The intersection of the nervous system and breast cancer
Yutong Liu, Shiqi Yin, Guanyu Lu, et al.
Cancer Letters (2024) Vol. 598, pp. 217132-217132
Closed Access | Times Cited: 12

YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer
Shuai Yuan, Shu Xi, Hong Weng, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 12, pp. 2477-2490
Closed Access | Times Cited: 22

ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis
Xiaoqi Mao, Jin Xu, Mingming Xiao, et al.
Redox Biology (2024) Vol. 73, pp. 103200-103200
Open Access | Times Cited: 7

PTEN: an emerging target in rheumatoid arthritis?
Zhou Pan, Xingwen Meng, Zhimin Nie, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets
Fenghe Li, Chong Zeng, Jie Liu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 4

Loss of YTHDC1 m6A reading function promotes invasiveness in urothelial carcinoma of the bladder
Jinyun Xu, Jonas P. Koch, Claudia Schmidt, et al.
Experimental & Molecular Medicine (2025)
Open Access

Suppressing the progression of bladder cancer using cyclovirobuxine D based on network pharmacology and bioinformatics approaches
Ke Gao, Hanbing Jiang, Chao Zhang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access

Two multifunctional zero-dimensional Gd(III) complexes: Magnetocaloric effect, inhibition of cell proliferation, migration and induction of apoptosis in lung cancer cells
Shouying Cao, Yaqing Xie, Xiaotong Lu, et al.
Journal of Inorganic Biochemistry (2025) Vol. 265, pp. 112832-112832
Closed Access

High-glucose-associated YTHDC1 lactylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy
Zhuo Xing, Tiejun Yang, Xurui Li, et al.
Cell Reports (2025) Vol. 44, Iss. 4, pp. 115545-115545
Open Access

Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer
Jie Liu, Xinyu Gu, Zhenjie Guan, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9

Bioinformatics analysis and experimental validation reveal that CDC20 overexpression promotes bladder cancer progression and potential underlying mechanisms
Yuan Liu, Shao-hui Zou, Xin Gao
Genes & Genomics (2024) Vol. 46, Iss. 4, pp. 437-449
Closed Access | Times Cited: 3

Liquid–liquid phase separation in diseases
Xinyue Zhang, Yuan Lin, Wanlu Zhang, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 3

YTHDC1 m6A-dependent and m6A-independent functions converge to preserve the DNA damage response
Daniel Elvira-Blázquez, José Miguel Fernández-Justel, Aída Arcas, et al.
The EMBO Journal (2024) Vol. 43, Iss. 16, pp. 3494-3522
Open Access | Times Cited: 2

Plk3 Enhances Cisplatin Sensitivity of Nonsmall-Cell Lung Cancer Cells through Inhibition of the PI3K/AKT Pathway via Stabilizing PTEN
Mengshan Xu, Xiaoyun Deng, Nana Xiang, et al.
ACS Omega (2024) Vol. 9, Iss. 8, pp. 8995-9002
Open Access | Times Cited: 1

Multi-omics comprehensive analysis reveals the predictive value of N6-methyladenosine- related genes in prognosis and immune escape of bladder cancer
Yang Liu, Zhong-Qi Pang, Jianshe Wang, et al.
Cancer Biomarkers (2024) Vol. 40, Iss. 1, pp. 79-94
Open Access | Times Cited: 1

Ramifications of m6A Modification on ncRNAs in Cancer
Rashid Mehmood
Current Genomics (2024) Vol. 25, Iss. 3, pp. 158-170
Open Access | Times Cited: 1

Unraveling the Role of Long Non-Coding RNAs in Therapeutic Resistance in Acute Myeloid Leukemia: New Prospects & Challenges
Siddhant Sharma
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1203-1221
Open Access | Times Cited: 1

The diverse landscape of RNA modifications in cancer development and progression
Hyung Seok Kim, Jung Woo Eun, Seonghoe Jang, et al.
Genes & Genomics (2024)
Closed Access | Times Cited: 1

Epitranscriptomic RNA m6A Modification in Cancer Therapy Resistance: Challenges and Unrealized Opportunities
Mohammad B. Uddin, Zhishan Wang, Chengfeng Yang
Advanced Science (2024)
Open Access | Times Cited: 1

The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression
Wenhao Zhu, Renshan Zhao, Xiaomin Guan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3

Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer
Rin Himura, Shinya Kawano, Yujiro Nagata, et al.
Chemico-Biological Interactions (2023) Vol. 388, pp. 110840-110840
Closed Access | Times Cited: 3

YTHDC1 m6A-dependent and m6A-independent functions converge to preserve DNA damage response.
Daniel Elvira-Blázquez, José Miguel Fernández-Justel, Aída Arcas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Evaluation of miRNA 130a-3P and miRNA 301a-3P in Egyptian patients with urinary bladder carcinoma
Eman Masoud Abd El Gayed, Maha A. f. Hamouda, S. Elsobky, et al.
Human Gene (2024) Vol. 41, pp. 201313-201313
Closed Access

Page 1 - Next Page

Scroll to top